scholarly journals An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel Antimalarials

2020 ◽  
Author(s):  
Edwin Tse ◽  
Laksh Aithani ◽  
Mark Anderson ◽  
Jonathan Cardoso-Silva ◽  
Giovanni Cincilla ◽  
...  
Keyword(s):  
Machine Learning ◽  
Drug Discovery ◽  
Predictive Models ◽  
Structural Information ◽  
Open Data ◽  
Ion Pump ◽  
Learning Methods ◽  
Machine Learning Methods

<p>The discovery of new antimalarial medicines with novel mechanisms of action is key to combating the problem of increasing resistance to our frontline treatments. The Open Source Malaria (OSM) consortium has been developing compounds ("Series 4") that have potent activity against <i>Plasmodium falciparum</i> <i>in vitro</i> and <i>in vivo</i> and that have been suggested to act through the inhibition of <i>Pf</i>ATP4, an essential membrane ion pump that regulates the parasite’s intracellular Na<sup>+</sup> concentration. The structure of <i>Pf</i>ATP4 is yet to be determined. In the absence of structural information about this target, a public competition was created to develop a model that would allow the prediction of anti-<i>Pf</i>ATP4 activity among Series 4 compounds, thereby reducing project costs associated with the unnecessary synthesis of inactive compounds.</p>In the first round, in 2016, six participants used the open data collated by OSM to develop moderately predictive models using diverse methods. Notably, all submitted models were available to all other participants in real time. Since then further bioactivity data have been acquired and machine learning methods have rapidly developed, so a second round of the competition was undertaken, in 2019, again with freely-donated models that other participants could see. The best-performing models from this second round were used to predict novel inhibitory molecules, of which several were synthesised and evaluated against the parasite. One such compound, containing a motif that the human chemists familiar with this series would have dismissed as ill-advised, was active. The project demonstrated the abilities of new machine learning methods in the prediction of active compounds where there is no biological target structure, frequently the central problem in phenotypic drug discovery. Since all data and participant interactions remain in the public domain, this research project “lives” and may be improved by others.

scholarly journals An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel Antimalarials

2020 ◽  
Author(s):  
Edwin Tse ◽  
Laksh Aithani ◽  
Mark Anderson ◽  
Jonathan Cardoso-Silva ◽  
Giovanni Cincilla ◽  
...  
Keyword(s):  
Machine Learning ◽  
Drug Discovery ◽  
Predictive Models ◽  
Structural Information ◽  
Open Data ◽  
Ion Pump ◽  
Learning Methods ◽  
Machine Learning Methods

<p>The discovery of new antimalarial medicines with novel mechanisms of action is key to combating the problem of increasing resistance to our frontline treatments. The Open Source Malaria (OSM) consortium has been developing compounds ("Series 4") that have potent activity against <i>Plasmodium falciparum</i> <i>in vitro</i> and <i>in vivo</i> and that have been suggested to act through the inhibition of <i>Pf</i>ATP4, an essential membrane ion pump that regulates the parasite’s intracellular Na<sup>+</sup> concentration. The structure of <i>Pf</i>ATP4 is yet to be determined. In the absence of structural information about this target, a public competition was created to develop a model that would allow the prediction of anti-<i>Pf</i>ATP4 activity among Series 4 compounds, thereby reducing project costs associated with the unnecessary synthesis of inactive compounds.</p>In the first round, in 2016, six participants used the open data collated by OSM to develop moderately predictive models using diverse methods. Notably, all submitted models were available to all other participants in real time. Since then further bioactivity data have been acquired and machine learning methods have rapidly developed, so a second round of the competition was undertaken, in 2019, again with freely-donated models that other participants could see. The best-performing models from this second round were used to predict novel inhibitory molecules, of which several were synthesised and evaluated against the parasite. One such compound, containing a motif that the human chemists familiar with this series would have dismissed as ill-advised, was active. The project demonstrated the abilities of new machine learning methods in the prediction of active compounds where there is no biological target structure, frequently the central problem in phenotypic drug discovery. Since all data and participant interactions remain in the public domain, this research project “lives” and may be improved by others.

A NOVEL EXTENSIVE EX-VIVO OCT DATABASE FROM MURINE MODELS OF COLORECTAL CANCER

2021 ◽  
Vol 108 (Supplement_3) ◽  
Author(s):  
J Bote ◽  
J F Ortega-Morán ◽  
C L Saratxaga ◽  
B Pagador ◽  
A Picón ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Machine Learning ◽  
Structural Information ◽  
Ex Vivo ◽  
Ground Truth ◽  
Colon Polyps ◽  
Learning Methods ◽  
Non Invasive ◽  
Machine Learning Methods ◽  
In Situ Methods

Abstract INTRODUCTION New non-invasive technologies for improving early diagnosis of colorectal cancer (CRC) are demanded by clinicians. Optical Coherence Tomography (OCT) provides sub-surface structural information and offers diagnosis capabilities of colon polyps, further improved by machine learning methods. Databases of OCT images are necessary to facilitate algorithms development and testing. MATERIALS AND METHODS A database has been acquired from rat colonic samples with a Thorlabs OCT system with 930nm centre wavelength that provides 1.2KHz A-scan rate, 7μm axial resolution in air, 4μm lateral resolution, 1.7mm imaging depth in air, 6mm x 6mm FOV, and 107dB sensitivity. The colon from anaesthetised animals has been excised and samples have been extracted and preserved for ex-vivo analysis with the OCT equipment. RESULTS This database consists of OCT 3D volumes (C-scans) and 2D images (B-scans) of murine samples from: 1) healthy tissue, for ground-truth comparison (18 samples; 66 C-scans; 17,478 B-scans); 2) hyperplastic polyps, obtained from an induced colorectal hyperplastic murine model (47 samples; 153 C-scans; 42,450 B-scans); 3) neoplastic polyps (adenomatous and adenocarcinomatous), obtained from clinically validated Pirc F344/NTac-Apcam1137 rat model (232 samples; 564 C-scans; 158,557 B-scans); and 4) unknown tissue (polyp adjacent, presumably healthy) (98 samples; 157 C-scans; 42,070 B-scans). CONCLUSIONS A novel extensive ex-vivo OCT database of murine CRC model has been obtained and will be openly published for the research community. It can be used for classification/segmentation machine learning methods, for correlation between OCT features and histopathological structures, and for developing new non-invasive in-situ methods of diagnosis of colorectal cancer.

scholarly journals Identification of Novel Plant Peroxisomal Targeting Signals by a Combination of Machine Learning Methods and in Vivo Subcellular Targeting Analyses

2011 ◽  
Vol 23 (4) ◽  
pp. 1556-1572 ◽  
Author(s):  
Thomas Lingner ◽  
Amr R. Kataya ◽  
Gerardo E. Antonicelli ◽  
Aline Benichou ◽  
Kjersti Nilssen ◽  
...  
Keyword(s):  
Machine Learning ◽  
Subcellular Targeting ◽  
Learning Methods ◽  
Machine Learning Methods ◽  
Peroxisomal Targeting ◽  
Targeting Signals

scholarly journals Development of Predictive Models for Identifying Potential S100A9 Inhibitors Based on Machine Learning Methods

2019 ◽  
Vol 7 ◽  
Author(s):  
Jihyeun Lee ◽  
Surendra Kumar ◽  
Sang-Yoon Lee ◽  
Sung Jean Park ◽  
Mi-hyun Kim
Keyword(s):  
Machine Learning ◽  
Predictive Models ◽  
Learning Methods ◽  
Machine Learning Methods

The QSAR Paradigm in Fragment-Based Drug Discovery: From the Virtual Generation of Target Inhibitors to Multi-Scale Modeling

2020 ◽  
Vol 20 (14) ◽  
pp. 1357-1374 ◽  
Author(s):  
Valeria V. Kleandrova ◽  
Alejandro Speck-Planche
Keyword(s):  
Drug Discovery ◽  
Structural Information ◽  
Biological Data ◽  
Heterogeneous Databases ◽  
Biomedical Sciences ◽  
Multi Scale ◽  
Scale Modeling ◽  
Multi Scale Modeling

Fragment-Based Drug Design (FBDD) has established itself as a promising approach in modern drug discovery, accelerating and improving lead optimization, while playing a crucial role in diminishing the high attrition rates at all stages in the drug development process. On the other hand, FBDD has benefited from the application of computational methodologies, where the models derived from the Quantitative Structure-Activity Relationships (QSAR) have become consolidated tools. This mini-review focuses on the evolution and main applications of the QSAR paradigm in the context of FBDD in the last five years. This report places particular emphasis on the QSAR models derived from fragment-based topological approaches to extract physicochemical and/or structural information, allowing to design potentially novel mono- or multi-target inhibitors from relatively large and heterogeneous databases. Here, we also discuss the need to apply multi-scale modeling, to exemplify how different datasets based on target inhibition can be simultaneously integrated and predicted together with other relevant endpoints such as the biological activity against non-biomolecular targets, as well as in vitro and in vivo toxicity and pharmacokinetic properties. In this context, seminal papers are briefly analyzed. As huge amounts of data continue to accumulate in the domains of the chemical, biological and biomedical sciences, it has become clear that drug discovery must be viewed as a multi-scale optimization process. An ideal multi-scale approach should integrate diverse chemical and biological data and also serve as a knowledge generator, enabling the design of potentially optimal chemicals that may become therapeutic agents.

scholarly journals Electrical impedance characterization of in vivo porcine tissue using machine learning

2021 ◽  
Vol 12 (1) ◽  
pp. 26-33
Author(s):  
Stephen Chiang ◽  
Matthew Eschbach ◽  
Robert Knapp ◽  
Brian Holden ◽  
Andrew Miesse ◽  
...  
Keyword(s):  
Machine Learning ◽  
Small Bowel ◽  
Electrical Impedance ◽  
Tissue Type ◽  
Support Vector ◽  
Learning Methods ◽  
K Nearest Neighbors ◽  
Porcine Tissue ◽  
Machine Learning Methods

Abstract The incorporation of sensors onto the stapling platform has been investigated to overcome the disconnect in our understanding of tissue handling by surgical staplers. The goal of this study was to explore the feasibility of in vivo porcine tissue differentiation using bioimpedance data and machine learning methods. In vivo electrical impedance measurements were obtained in 7 young domestic pigs, using a logarithmic sweep of 50 points over a frequency range of 100 Hz to 1 MHz. Tissues studied included lung, liver, small bowel, colon, and stomach, which was further segmented into fundus, body, and antrum. The data was then parsed through MATLAB's classification learner to identify the best algorithm for tissue type differentiation. The most effective classification scheme was found to be cubic support vector machines with 86.96% accuracy. When fundus, body and antrum were aggregated together as stomach, the accuracy improved to 88.03%. The combination of stomach, small bowel, and colon together as GI tract improved accuracy to 99.79% using fine k nearest neighbors. The results suggest that bioimpedance data can be effectively used to differentiate tissue types in vivo. This study is one of the first that combines in vivo bioimpedance tissue data across multiple tissue types with machine learning methods.

A Very Large-Scale Bioactivity Comparison of Deep Learning and Multiple Machine Learning Algorithms for Drug Discovery

2020 ◽  
Author(s):  
Thomas R. Lane ◽  
Daniel H. Foil ◽  
Eni Minerali ◽  
Fabio Urbina ◽  
Kimberley M. Zorn ◽  
...  
Keyword(s):  
Machine Learning ◽  
Neural Networks ◽  
Deep Learning ◽  
Drug Discovery ◽  
Deep Neural Networks ◽  
Learning Algorithms ◽  
Machine Learning Algorithms ◽  
Support Vector ◽  
Learning Methods ◽  
Machine Learning Methods

<p>Machine learning methods are attracting considerable attention from the pharmaceutical industry for use in drug discovery and applications beyond. In recent studies we have applied multiple machine learning algorithms, modeling metrics and in some cases compared molecular descriptors to build models for individual targets or properties on a relatively small scale. Several research groups have used large numbers of datasets from public databases such as ChEMBL in order to evaluate machine learning methods of interest to them. The largest of these types of studies used on the order of 1400 datasets. We have now extracted well over 5000 datasets from CHEMBL for use with the ECFP6 fingerprint and comparison of our proprietary software Assay Central<sup>TM</sup> with random forest, k-Nearest Neighbors, support vector classification, naïve Bayesian, AdaBoosted decision trees, and deep neural networks (3 levels). Model performance <a>was</a> assessed using an array of five-fold cross-validation metrics including area-under-the-curve, F1 score, Cohen’s kappa and Matthews correlation coefficient. <a>Based on ranked normalized scores for the metrics or datasets all methods appeared comparable while the distance from the top indicated Assay Central<sup>TM</sup> and support vector classification were comparable. </a>Unlike prior studies which have placed considerable emphasis on deep neural networks (deep learning), no advantage was seen in this case where minimal tuning was performed of any of the methods. If anything, Assay Central<sup>TM</sup> may have been at a slight advantage as the activity cutoff for each of the over 5000 datasets representing over 570,000 unique compounds was based on Assay Central<sup>TM</sup>performance, but support vector classification seems to be a strong competitor. We also apply Assay Central<sup>TM</sup> to prospective predictions for PXR and hERG to further validate these models. This work currently appears to be the largest comparison of machine learning algorithms to date. Future studies will likely evaluate additional databases, descriptors and algorithms, as well as further refining methods for evaluating and comparing models. </p><p><b> </b></p>

Sign in / Sign up

Export Citation Format

Share Document